We demonstrated that disruption of TLK1>NEK1 axis sensitizes the PCa cells to low doses of doxorubicin treatment by reducing VDAC1 S193 phosphorylation and its stability. The gene discussed is TLK1; the disease is posterior cortical atrophy.